Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)6.41
  • Today's Change0.22 / 3.55%
  • Shares traded89.00
  • 1 Year change+137.41%
  • Beta3.4695
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments637160
Total Receivables, Net3.407.004.40
Total Inventory------
Prepaid expenses2.553.344.99
Other current assets, total180.400.41
Total current assets868270
Property, plant & equipment, net3.846.499.97
Goodwill, net134134134
Intangibles, net441443444
Long term investments1.011.761.76
Note receivable - long term------
Other long term assets2.102.331.93
Total assets669669662
LIABILITIES
Accounts payable7.072023
Accrued expenses7.442.013.33
Notes payable/short-term debt000
Current portion long-term debt/capital leases16108.20
Other current liabilities, total429.8117
Total current liabilities734251
Total long term debt10210699
Total debt119116107
Deferred income tax----0
Minority interest------
Other liabilities, total131915
Total liabilities189168165
SHAREHOLDERS EQUITY
Common stock1,3111,2491,165
Additional paid-in capital------
Retained earnings (accumulated deficit)(789)(706)(628)
Treasury stock - common------
Unrealized gain (loss)(1.29)(0.54)(0.54)
Other equity, total(40)(40)(40)
Total equity480502497
Total liabilities & shareholders' equity669669662
Total common shares outstanding1,141858325
Treasury shares - common primary issue0.540.270.27
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.